Xcout Intel
HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC
VQ Biomedical develops a minimally-invasive intravascular oxygenation catheter designed to deliver supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure. The technology provides gas exchange independently of injured lungs to support healing while avoiding the complications of mechanical ventilation or external ECMO pumps. The company serves healthcare providers and critical care patients.
Subscribe to see HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Recent HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC news
- FundingPrivate placement (Form D)
HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC competitors
A few of HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC's closest competitors — see the full list of competitors and alternatives →
ALung Technologies develops extracorporeal respiratory support devices, including the Hemolung Respiratory Assist System, designed to remove carbon dioxide from blood and support patients with acute respiratory failure. Its products are intended for hospitals and critical-care clinicians treating patients who need respiratory support, including certain patients with severe COPD or who may otherwise require mechanical ventilation.
Securisyn Medical develops medical devices designed to prevent unplanned extubation, featuring products such as the SolidAIRity Flex adult endotracheal securement device and an upcoming pediatric version. The company serves healthcare providers and patients by offering securement solutions for artificial airways.
Endolynx Inc. develops sensor-enabled endotracheal tubes equipped with proprietary technology for real-time depth tracking and position verification. The company's products serve healthcare providers in hospitals, emergency situations, and intensive care units by preventing tube misplacement and displacement complications.
Turn Medical develops and provides automated prone positioning solutions and related therapies for critically ill patients in healthcare facilities. Its flagship product, the Pronova-O2 Automated Prone Therapy System, offers automated prone therapy, continuous lateral rotation, and skin protection to assist caregivers and improve patient outcomes.
STIMIT Corp develops non-invasive diaphragm stimulation technology designed to re-activate breathing and preserve diaphragm muscle function in mechanically ventilated patients. The company serves the respiratory critical care sector by providing medical devices aimed at helping patients recover natural breathing.
Flow Forward Medical develops an all-in-one, steerable catheter system designed for interventional pulmonary embolism treatment, combining angiography, infusion, and real-time monitoring capabilities. The company serves medical providers by streamlining procedures, optimizing lytic delivery, and tracking clot resolution to improve patient outcomes.
Get HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on HB-WIN 2026 VQ Biomedical Series - a series of HB-WIN LLC in Xcout Intel
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access